Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

NCT01677455

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Synta Pharmaceuticals Investigative Site Birmingham, Alabama, United States
  • Synta Pharmaceuticals Investigative Site Altanta, Georgia, United States
  • Synta Pharmaceuticals Investigative Site Boston, Massachusetts, United States
  • Synta Pharmaceuticals Investigative Site New York, United States
View all 25 locations
View Trial Details
Completed

Triple Negative Breast Cancer Biomarker Study

NCT01111175

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +6 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Virginia Oncology Assocites Elizabeth City, North Carolina, United States
  • Northwest Cancer Specialists, P.C. Portland, Oregon, United States
  • Northwest Cancer Specialists, P.C. Portland, Oregon, United States
View all 18 locations
View Trial Details
Suspended

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

NCT04638751

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +29 more
Locations
  • Knowledge Research Center Orange, California, United States
  • SDG Clinical Research, Inc San Diego, California, United States
  • Persephone Biosciences, Inc. San Diego, California, United States
  • L&A Morales Healthcare, Inc Miami, Florida, United States
View Trial Details

Related conditions